Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06774326
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View on ClinicalTrials.gov
Summary
To evaluate the diagnostic capability of Spectral CT (performed with contrast agent as part of routine oncological follow-up) in detecting signs of acute and chronic early-onset cardiac toxicity from anthracyclines in patients with Hodgkin's lymphoma and diffuse large B-cell lymphoma undergoing treatment regimens that include a drug from this family.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
160
Start Date
2024-02-14
Completion Date
2029-08
Last Updated
2025-01-14
Healthy Volunteers
No
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy